FDA Proposes New Approval Pathway for Ultra-Rare Disease Therapies
U.S. Food and Drug Administration unveils new pathway to approve individualized therapies for ultra-rare genetic disease.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.